Aura Biosciences (AURA) Change in Accured Expenses (2020 - 2026)

Aura Biosciences has reported Change in Accured Expenses for 7 years, with the latest figure at -$2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 10.91% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 93.34% YoY), and the FY2025 full-year result was $4.1 million, up 161.95% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$2.7 million, down from -$124000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $3.4 million in Q2 2025, with the low at -$2.9 million in Q1 2024.
• Historically, Change in Accured Expenses has averaged $382764.7 across 5 years, with a median of $1.0 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 315.98% — and 2025, when it sank 629.41%.
• Aura Biosciences' Change in Accured Expenses stood at -$701000.0 in 2022, then surged by 315.98% to $1.5 million in 2023, then sank by 101.12% to -$17000.0 in 2024, then slumped by 629.41% to -$124000.0 in 2025, then plunged by 2113.71% to -$2.7 million in 2026.
• The last three Change in Accured Expenses figures came in at -$2.7 million (Q1 2026), -$124000.0 (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.